With a market cap of has a large market cap size. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has been on the stock market since its IPO date on the 7/26/1999. BioMarin Pharmaceutical Inc. is in the Biotechnology industry and Healthcare sector. Average volume for BioMarin Pharmaceutical Inc., is 1670.9, and so far today it has a volume of 1244464. Performance year to date since the 7/26/1999 is -5.10%.
To help you determine whether BioMarin Pharmaceutical Inc. is undervalued the following values will help you decide. P/E is *TBA and forward P/E is *TBA. PEG perhaps more useful shows that BioMarin Pharmaceutical Inc. has a value for PEG of *TBA. P/S ratio is 17.25 and the P/B ratio is 7.01. The P/Cash and P/Free cash flow is 34.89 and *TBA respectively.
At the current price BioMarin Pharmaceutical Inc. is trading at, 99.98 (0.56% today), BioMarin Pharmaceutical Inc. has a dividend yield of *TBA, and this is covered by a payout ratio of *TBA. Earnings per share (EPS) is -1.18, and this is looking to grow in the next year to 38.50% after growing -17.30% this past year. EPS growth quarter over quarter is 38.50%, and -41.70% for sales growth quarter over quarter.
The number of shares outstanding is 160.33, and the number of shares float is 160.33. The senior management bring insider ownership to 0.60%, and institutional ownership is at 100.00%. The float short is 3.59%, with the short ratio at a value of 3.45. Management has seen a return on assets of -5.20%, and also a return on investment of -4.20%.
The ability for BioMarin Pharmaceutical Inc., to deal with debt, means it current ratio is 2.6, and quick ratio is 1.8. Long term debt/equity is 0.29 and total debt/equity is 0.29. In terms of margins, BioMarin Pharmaceutical Inc. has a gross margin of 82.40%, with its operating margin at -13.60%, and BioMarin Pharmaceutical Inc. has a profit margin of -20.50%.
The 52 week high is -32.58%, with 60.95% being its 52 week low. The 20 day simple moving average is 15.44% and the 200 day simple moving average is 11.41%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.